(GPI). T and B cells are both required for disease initia-
in serum-induced disease. Both high-affinity, Fc␥RI, and At this point, it is important to delve more deeply: low-affinity, Fc␥RIII, employ the common ␥ chain, FcR␥ which particular FcRs and complement components are (as does Fc⑀RI). Therefore, as a first look, we evaluated involved in RA? Where do they intervene in the disease the effect of the FcR␥ null mutation (Takai et al., 1994) . process? What is the relationship between these two Serum from arthritic K/BxN mice was injected into effector arms? This latter question is of particular interFcR␥ Ϫ/Ϫ recipients and control littermates, and diverse est given the recent suggestion that only one or the other disease parameters were followed over time (Figures of these arms usually dominates any given inflammatory 1A and 1B). Arthritis arose in all control animals, any response (Ravetch and Clynes, 1998).
heterogeneity almost certainly reflecting their mixed We have chosen to examine these issues in K/BxN (B6x129/Sv) genetic background. Here, we establish a critical role for both FcRs and serum-transferred arthritis, we initially focused on C5 for K/BxN serum was injected into C5-deficient and C5-sufficient A/J congenic mice, and signs of arthritis were monitored over time (Figure 2A ). Mice lacking C5 two major reasons. First, C5 is pivotal in the complement showed no signs of disease development. Since the C5-network, both effector pathways leading from it and the deficient strain was a congenic rather than a knockout three initiating pathways leading into it. Second, the variant, it was necessary to confirm that the lack of critical reagents needed for such a study were available, response to arthritogenic serum was due to the defective C5 gene itself and not to some adjacent genetic both a C5-deficient mouse strain (Gervais et al., 1989) The three initiating pathways leading into C5 and the two effector pathways leading from them are schematized. Tabulated next to a particular component is the effect of its deficiency, assessed for each case in at least two independent experiments, each with at least two individual mutant mice. Scoring was as described in Experimental Procedures. Arth. represents the proportion of affected mice, AvAT the average max ankle swelling. Absence of arthritis corresponds to no clinical signs at all. Blue ovals signify no effect; red ovals reflect significant inhibition. MBL is shown as half-blue/half-white because an MBP-A deficiency showed no effect, but an MBP-C deficiency has not yet been tested. The asterisks for C3 and fB indicate very weak disease manifestations.
variation. Therefore, recipients of K/BxN serum were being careful to compare control animals that were the most closely genetically matched possible. The data treated with anti-C5 mAb starting from 2 days before serum injection ( Figure 2B ). These animals also showed are summarized and oriented within the complement network in Figure 3 ; results from representative individno signs of disease. Interestingly, anti-C5 mAb treatment could also reverse ongoing disease when injected ual experiments for each mutant strain are presented in Figure 4A . several days after arthritis onset ( Figure 2C The dispensability of the classical pathway raised the question of whether C5 might not be directly cleaved series. Important clues to how these influences might be integrated could come from delineating when precisely by proteases derived from invading inflammatory cells, in particular neutrophils, as has been described in some they impinge on disease progression or from identifying partial or transient phenotypes in their absence. contexts (Wetsel and Kolb, 1983) . If this notion were true, serum-induced disease would be C3 independent.
First, we applied a recently developed in vivo imaging strategy to visualization of the early stages of serumThis turned out not to be the case: there was a strong inhibition of arthritis development in C3 null mice (Westransferred arthritis. This approach, already applied in neoplastic settings, relies on protease-activated near sels et al., 1995) (Figures 3 and 4) , although, interestingly, it was not as profound a block as was seen in C5aR-infra-red fluorescent (NIRF) probes to detect the enhanced endocytic/phagocytic and protease activities deficient animals. Unlike the latter strain, the former showed mild swelling in the occasional paw, as well as characteristic of infiltrating leukocytes (e.g., macrophages, dendritic cells, neutrophils) (Weissleder et al., sporadic histological signs such as synovial hyperplasia and infiltration. 1999). Fluorochrome tags are conjugated to a protected graft copolymer at high density, resulting in their To assess the contribution of the alternative pathway, we analyzed disease induction in mice devoid of factor quenching; also incorporated into the copolymer are recognition sites for cathepsin B; cleavage at these sites B (Watanabe et al., 2000) . Most of these animals did not develop arthritis upon K/BxN serum transfer, although releases the tags, permitting imaging via external illumination since both the excitation and emission wavea few did show some weak clinical and histological signs-occasional joint swelling, synovial hyperplasia, lengths of the fluorochrome can traverse soft tissue. Mice were iv-injected with this probe and visualization and sparse leukocyte infiltrates (Figures 3 and 4) . This distinctly muted response was reminiscent of that obperformed by NIRF reflectance imaging. As illustrated in Figure 5A , for a 60-day-old K/BxN TCR tg mouse, served with C3 null animals.
The critical issue then became what activates/amplistrong fluorescence could be visualized over the ankle and some of the digits in arthritic animals, while such a fies the alternative pathway. A major mechanism is thought to be amplification via C3b fragment generated signal was not detectable in nonarthritic controls. Clear fluorescence was also detected, albeit not as strongly, Figures 3 and 4) , leaving open the possibilities that MBP-C or either one of the plement activation via immunohistology, testing for complement deposition by staining joint sections with two plays a required role, or that the MBLectin pathway is not involved.
anti-C3 reagents. As shown in Figure 6A , the arthritic lesion in wild-type recipients of K/BxN serum is accom-A related issue was whether and which complement receptors (CRs) might be involved in K/BxN serumpanied by C3 deposits in several areas of the joint-in the area of proliferative synovitis and very strikingly transferred arthritis. CR1 binds the C3b, iC3b, and C4b fragments; CR2, the C3d and iC3b fragments; and CR3, aligned along the cartilage surface. These correlate with IgG deposits at the same sites, evidenced in costaining the iC3b fragment. These interactions have been implicated in immune adherance of opsonized particles, experiments ( Figure 6A ). In FcR␥-deficient mice ( Figure  6B ), the C3 deposits were largely absent, although in phagocytosis, IC clearance, and signal transduction. As illustrated in Figure 4B , neither a combined deficiency three of the four animals examined, we noted small patches of mild but significant complement deposition. in CR1 and CR2 (Molina et al., 1996) nor a deficit in CR3 (Coxon et al., 1996) had a detectable effect on serumIgG deposits were also present, albeit in reduced amounts. In C5-deficient mice (Figure 6B ), the C3 and induced disease.
In summary, the critical role of the complement netIgG deposits were completely absent. The conclusion from this analysis is that both FcRs and the complement work in K/BxN serum-transferred arthritis is initiated via the alternative pathway and effected through C5a:C5aR network are required for cell recruitment/activation events at the earliest stages of arthritis but that compleinteractions. Factor B, C3, C5, and C5aR all have important influences on disease induction, whereas C1q, C4, ment is necessary and at least partially sufficient for the generation of the molecular aggregates that provoke MBP-A, and C6 and CRs 1, 2, and 3 are all dispensable. these events. , 1996] ). On the one hand, as we have discussed, they may bind and stabilize and it was assumed that the alternative pathway merely served to amplify a response initiated via the classical low levels of C3b "ticking over," aggregate into lattices at the cartilage surface, and seed assembly of C3 and route (Watanabe et al., 2000) . In light of our results, it is important to experimentally verify this assumption.
Integration of the FcR and Complement
C5 convertases, thereby initiating the alternative pathway of complement activation. The major role of the What initiates the alternative pathway in the K/BxN serum-transfer system-a pathway generally thought to C5a that is generated may be to recruit neutrophils, which would have multiple functions, a critical one being be focused on microbial surfaces? The possibility we favor is that mobilization of the alternative pathway is amplification of a complement activation loop feeding through the alternative pathway. On the other hand, through formation and stabilization of surface-bound 
